In a study of over 2 million individuals with type 2 diabetes mellitus, researchers investigated the effects of this condition on subsequent risk of developing Parkinson disease.
MORE EXCLUSIVES »
Researchers conducted a population-based case-control study using Medicare claims data from patients to further explore a potential inverse association between the use of immunosuppressing drugs and Parkinson disease risk.
Previous research has indicated that gastrointestinal inflammation may play a role in the development of parkinsonian disorders. With this in mind, the authors of a new study recently investigated whether the risk for Parkinson disease is elevated among patients with Crohn disease and ulcerative colitis.
Non-motor symptoms of PD have been shown to be associated with sleep disorders and impaired quality of life. In a recent study, researchers investigated the effects of continuous positive airway pressure treatment on symptoms of PD, including cognition, anxiety, and sleep quality.